The largest database of trusted experimental protocols

Abi prism 3100 avant genetic analyzer

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, Japan

The ABI PRISM 3100 Avant Genetic Analyzer is a DNA sequencing instrument designed for high-throughput genetic analysis. It utilizes capillary electrophoresis technology to separate and detect fluorescently labeled DNA fragments. The core function of the instrument is to perform automated DNA sequencing, fragment analysis, and genotyping applications.

Automatically generated - may contain errors

80 protocols using abi prism 3100 avant genetic analyzer

1

Genotyping of Microsatellite Markers and PJVK Gene Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from peripheral blood samples by using the Chemagic MSM I automated system (Chemagen, Baesweiler, Germany). Microsatellite markers D2S148, D2S2173, D2S324 and D2S2310 were amplified using fluorescently-labeled primers and PCR conditions as previously reported [30 (link)]. Amplified alleles were resolved by capillary electrophoresis in an ABI Prism 3100 Avant Genetic Analyzer (Applied Biosystems, Waltham, MA, USA). Primers and conditions for PCR amplification of all seven exons of the PJVK gene are shown in Table 1. Sanger DNA sequencing was performed in an ABI Prism 3100 Avant Genetic Analyzer (Applied Biosystems, Waltham, MA, USA).
+ Open protocol
+ Expand
2

Microsatellite Analysis of Genomic DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten microsatellite markers were used for the analysis [38 (link),39 (link),40 (link)]. The PCR mix contained 50 ng of genomic DNA, 0.25 µM of each primer, 0.2 mM each dNTP, 2 mM MgCl2, 1 × Euroclone reaction buffer and 2 U EuroTaq DNA polymerase (Euroclone®, Milan, Italy) in a total volume of 25 µL. The forward primer was labeled with FAM and HEX fluorochromes (Sigma-Aldrich, St. Louis, MO, USA). PCR reactions were performed in a C1000™ Thermal Cycler (Bio-rad, Hercules, CA, USA) under the following conditions: 94 °C for 5 min, 35 cycles at 94 °C for 30 s, 50 to 60 °C (depending on the SSR primer combination) for 30 s, and 72 °C for 30 s, and final elongation at 72 °C for 60 min. PCR products were separated using the ABI PRISM 3100 Avant Genetic Analyzer (Life Technologies, Carlsbad, CA, USA), using a mixture of 2 µL PCR reaction, 12 µL Hi-Di™ formamide (Life Technologies, Carlsbad, CA, USA), and 0.3 µL GeneScan™ 500 ROX™ size standard (Life Technologies, Carlsbad, CA, USA). Allele size was determined using GeneMapper® software version 3.7 (Applied Biosystems, Foster City, CA, USA).
+ Open protocol
+ Expand
3

Mutant c-kit Gene Sequencing in Canine Mast Cell Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
All dogs included in this study were previously referred for MCTs to the Animal
Medical Center at Tokyo University of Agriculture and Technology. After
appropriate surgical removal or fine needle aspiration of MCT specimens, total
RNA from each sample was extracted by using Isogen (Nippon Gene, Toyama, Japan)
and cDNA was synthesized with PrimeScript (Takara, Otsu, Japan). Polymerase
chain reaction (PCR) was performed using a c-kit-specific forward primer
(5′-GGA ATT CGC CAC CGC GAT GAG AGG CGC TCG CGG CGC
CT-3′), a c-kit-specific reverse primer (5′-CTC TGC
GGC CGC TCA CAC ATC TTC GTG TAC CAG CA-3′), and PrimeSTAR Max DNA
Polymerase (Takara), according to the manufacturer’s instructions.
The c-kit gene was sequenced using the BigDye Terminator v3.1 Cycle
Sequencing Kit (Life Technologies, Gaithersburg, MD), forward primers
corresponding to bases 243–263, 648–667,
1050–1069, 1484–1504, 1843–1862,
2205–2225, and 2639–2657, and a reverse primer
corresponding to bases 386–406 (GenBank accession no. AF044249).
Samples were analyzed using the ABI PRISM 3100-Avant Genetic Analyzer
(Life Technologies). All experiments using clinical samples complied with the
standards specified in the guidelines of the University Animal Care and Use
Committee of the Tokyo University of Agriculture and Technology.
+ Open protocol
+ Expand
4

Validating Genetic Variants by NGS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Variants identified by NGS-based approaches were amplified f r o mD N Ao ft h ei n d e xp a t i e n t sa n dP C Rp r o d u c t sw e r es equenced by BigDye Terminator method on an ABI PRISM ® 3100 Avant Genetic Analyzer (Life Technologies, Germany). Identified mutations were re-sequenced in independent experiments and tested for co-segregation within the families.
+ Open protocol
+ Expand
5

Microsatellite Genotyping of FAM-01

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microsatellite markers of three affected individuals of family FAM-01 (IV.1, IV.2 and IV.3) and their parents (III.1 and III.2) were genotyped using the ABI PRISM ® 3100 Avant Genetic Analyzer and GeneScan ® 3.7 software (Life Technologies, Germany). Primer sequences to amplify specific markers were taken from the UCSC genome browser (http://www.genome.ucsc.edu) and primers were designed according to the reference sequences. Primers are available on request.
+ Open protocol
+ Expand
6

Glycosphingolipid Analysis by xCGE-LIF

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously, glycosphingolipid (GSL) glycosylation was assessed by multiplexed capillary gel electrophoresis coupled to laser induced fluorescence (xCGE-LIF) detection using an ABI PRISM® 3100-Avant Genetic Analyzer (advanced biolab service GmbH, Munich, Germany) [30 (link)]. The procedure is described more in detail in Supplementary Methods. Annotation of peaks was performed by migration time alignment to our in-house database [30 (link)].
+ Open protocol
+ Expand
7

Amplification and Sequencing of A20 Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
To amplify different domains of genomic DNA that cover A20 exons 2–9 (coding region) and exon/intron junctions of the A20 gene according to the structure of the A20 gene, 11 pairs of primers were purchased (Additional file 1: Table S1). PCR was performed as described in our previous study [19 (link)]. The PCR products were used for mutation analysis of the A20 coding sequence by direct sequencing using the Big Dye Terminator v3.1 Cycle Sequencing Kit (Perkin Elmer, ABI) and the ABI PRISM 3100-Avant genetic analyzer. Direct sequencing was performed by Invitrogen Biotechnology Company. Sequences of different samples from patients with RA and healthy individuals were analyzed with BLAST software (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to identify polymorphisms or mutations in the A20 gene.
+ Open protocol
+ Expand
8

Optimizing α-Glucosidase Inhibitory Activity of Streptomyces costaricanus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 16S rDNA sequencing method was used to identify the isolated strain. Genomic DNA isolation was used to extract DNA from a potent AGIs strain [15] . The isolated DNA was ampli ed by PCR. The conserved gene of 16S rRNA was ampli ed by using 9F (5′-AGAGTTTGATCCTGGCTC-3′) as the forward primer and 926R (5′-CCGTCAATTCCTTTGAGTT-3′) as the reverse primer. The ampli ed gene was sequenced on ABI PRISM 3100 Avant Genetic Analyzer. Sequence alignments were analyzed using the program MegAlign DNAStar Culture conditions optimization Time and temperature culture Unless otherwise stated, S. costaricanus EBL.HB6 was cultivated in a 250 mL ask with 50 mL ISP2 medium at 28°C with 200 rpm shaking and pH of 7.2. Extracellular extract from the culturing medium was obtained and α-glucosidase inhibitory activity tests were carried out after 24, 48, 72, 86, 120, 144, 168, and 192 h to select the best culture time.
To select optimum temperature for the AGIs production, S. costaricanus EBL.HB6 was cultured at different temperature from 28 to 37°C on ISP2 medium at pH 7.2.
+ Open protocol
+ Expand
9

Fungal DNA Sequencing and Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fungal isolates were subjected to DNA sequencing analysis. Culture plates of each isolate were used for DNA extraction as described above. Conventional PCR was performed using a universal ITS1 and ITS4 primer set (White et al., 1990 (link); Table 1), which amplifies the ITS regions in fungi; the PCR protocol was initial denaturation at 95°C for 4 min, followed by 35 cycles of denaturation at 95°C for 1 min, annealing at 56°C for 1 min, and extension at 72°C for 2 min, with a final extension for 10 min at 72°C. Each conventional PCR product was purified with the NucleoSpin Gel and PCR Clean-up (Takara, Tokyo, Japan). DNA sequencing was performed in an ABI PRISM 3100-Avant Genetic Analyzer (Thermo Fisher Scientific, MA, United States) using the BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, MA, United States). Unincorporated dye terminators were removed with NucleoSEQ (Takara, Tokyo, Japan). Sequences were analyzed by BLAST3.
+ Open protocol
+ Expand
10

Molecular Analysis of Rare Neurodegenerative Disorder

Check if the same lab product or an alternative is used in the 5 most similar protocols
All 6 patients with suspected MLS were Japanese males with clinically suspected NA (table). Six healthy male controls and 6 male patients with ChAc were matched to suspected MLS cases by age. A further 6 heterozygous ChAc mutant carriers were used for the analyses. Lymphoblastoid cell lines from MLS_17 and a healthy control were established by SRL (Tokyo, Japan).
Coding and flanking regions of XK (NC_000023.10) and VPS13A (NC_000009.11) were analyzed by Sanger sequencing on an ABI PRISM 3100 Avant Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA).3 In the case of MLS_6, we performed a whole-genome sequence, long-range PCR covering the deletion region, and Sanger sequencing.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!